Retraction Notice to: Crystal Structure of a Complement Control Protein that Regulates Both Pathways of Complement Activation and Binds Heparan Sulfate Proteoglycans (Cell (2001) 104(2) (301–311), (S0092867401002148) (10.1016/S0092-8674(01)00214-8));Crystal structure of a complement control protein that regulates both pathways of complement activation and binds heparan sulfate proteoglycans

Cell

Volumn 104, Issue 2, 2001, Pages 301-311

  Murthy, Krishna H M ^a   Smith, Scott ^b   Ganesh, Vannakambadi ^a   Judge, Ken ^a   Mullin, Nick ^c   Barlow, Paul ^c   Ogata, Craig ^d   Kotwal, Girish ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Louisville School of Medicine   (United States)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT; PROTEOHEPARAN SULFATE; REGULATOR PROTEIN;

ANIMAL CELL; ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; COMPLEMENT ACTIVATION; CRYSTAL STRUCTURE; HEMOLYSIS; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN STRUCTURE;

ANIMALIA; MAMMALIA; VACCINIA; VACCINIA VIRUS;

EID: 0035951426     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2018.11.047     Document Type: Erratum

References (62)

1. Structure and function of complement receptors, CR1 (CD35) and CR2 (CD21)
2. Vaccinia virus complement control protein is capable of protecting xenoendothelial cells from antibody binding and killing by human complement and cytotoxic cells
3. Structural and functional analysis of C3 using monoclonal antibodies
4. Secondary structure of a complement control protein module by two-dimensional NMR
5. Solution structure of the fifth repeat of factor H-A second example of the complement control protein module
6. Solution structure of a pair of complement modules by NMR
7. Identification of a second heparin-binding domain in human complement factor H
8. A cluster of positively charged amino acids in the C4BP α-chain is crucial for C4b binding and factor I cofactor function
9. Adhesion mechanism of human β2-glycoprotein I to phospholipids based on its crystal structure
10. Ribbon models of macromolecules
11. Crystal structure of two CD46 domains reveals an extended measles virus-binding surface
12. Structure-guided identification of C3d residues essential for its binding to complement receptor 2 (CD21)
13. 'dm': An automated procedure for phase improvement by density modification
14. Mapping of epitopes, glycosylation sites and complement regulatory domains in human decay acceleration factor
15. Structure of a heparin-linked biologically active dimer of fibroblast growth factor
16. Heparin structure and interactions with basic fibroblast growth factor
17. Complement C3: A molecular mosaic of binding sites
18. Crystal structure of the catalytic domain of human complement C1s: A serine protease with a handle
19. Solution structure and dynamics of the central CP module pair of a poxvirus complement control protein
20. MAD phasing in crystallography
21. The localization of heparin-binding fragments on human C4b-binding protein
22. Novel subunit in C4b-binding protein required for protein S binding
23. Molecular mimicry of the inflammation modulatory proteins (IMPs) of poxviruses: Evasion of the inflammatory response to preserve viral habitat
24. The classical pathway
25. Vaccinia virus complement-control protein prevents antibody-dependent complement-enhanced neutralization of infectivity and contributes to virulance
26. Improved methods for building protein models in electron density and location of errors in these models
27. Central modules of the vaccinia virus complement control protein are not in extensive contact
28. Purification of virokines using ultrafiltration
29. Poxvirus mimicry of complement and chemokine system components: What's the end game?
30. Vaccinia virus encodes a secretory polypeptide structurally related to complement control proteins
31. Inhibition of the complement cascade by the major secretory protein of vaccinia virus
32. The inflammation modulatory protein (IMP) of cowpox virus drastically diminishes the tissue damage by down-regulating cellular infiltration resulting from complement activation
33. The use of multiple wave-length anomalous diffraction in ab initio phase determination
34. Structure-function analysis of the active sites of complement receptor type 1
35. Membrane cofactor proteins (MCP or CD46): Newest member of the regulation of complement activation gene cluster
36. Dissecting sites important for complemant regulatory activity in membrane cofactor protein (MCP;CD46)
37. Therapeutic inhibition of the complement system
38. Comparative analysis of structurally defined heparin binding sequences reveals a distinct spatial distribution of basic residues
39. Regulation of complement activity by vaccinia virus complement-control protein
40. Regulation of alternative pathway complement activation by glycoseamnoglycans: Specificity of the polyanion binding site on factor H
41. The cowpox virus encoded homolog of the vaccinia virus complement control protein is an inflammtion modulatory protein
42. Charactrization of a complement receptor 2 (CR2, CD21) ligand binding site for C3. An initial model of ligand interaction with two linked short consensus repeat modules
43. X-ray crystal structure of C3d: A C3 fragment and ligand for complement receptor 2
44. Protein folding and association: Insights from the interfacial and thermodynamic properties of hydrocarbons
45. Identification of residues within the 727-767 segment of human complement component C3 important for its interaction with factor H and with complement receptor 1 (CR1,CD35)
46. The alternative pathway
47. Localization of the heparin-binding site on complement factor H
48. The finer things in X-ray diffraction data collection
49. Characterization of C3dg binding to a recess formed between consensus repeats 1 and 2 of complement receptor type 2
50. Structure functions relationships of the complement components
51. Heparin binding activity of vaccinia virus complement control protein confers additional properties of uptake by mast cells and attachment to endothelial cells
52. Interaction of vaccinia virus complement control protein with human complement proteins: Factor I mediated degradation of C3b to iC3b1 inactivates the alternative complement pathway
53. Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization
54. Crystal structure of human β2-glycoprotein I: Implications for phospholipid binding and the antiphospholipid syndrome
55. Identification of 3 physically and functionally distinct binding sites for C3b on human complement factor H by deletion mutagenesis
56. Surface exposed conserved K/R-X-K/R sites and positive charge on poxviral complement control proteins contribute to heparin binding and to inhibition of molecular interactions with human endothelial cells: A novel mechanism for evasion of host defense
57. Prediction from sequence comparisons of residues of factor H involved in interaction with complement component C3b
58. Automated MAD and MIR structure solution
59. NMR studies of a viral protein that mimics regulators of complement activation